CitizenLink: Senate Lacks Votes to Override Veto on Embryonic Stem-Cell Bill:


Senate Lacks Votes to Override Veto on Embryonic Stem-Cell Bill

by Jennifer Mesko, associate editor

In a medical first, adult stem cells shown to cure young diabetics.

The U.S. Senate voted 63-34 today in favor of S. 5, which would allow federal tax dollars to be used as an incentive to destroy human embryos for stem-cell research. President Bush has promised a veto, and 67 votes were needed to override that veto.

“That would be the end of the bill, but not the end of the issue,” said Douglas Johnson, legislative director for the National Right to Life Committee. He said he expects the bill to come up again next year.

Supporters of S. 5, continue to argue that embryonic stem cells hold the most promise for medical breakthroughs and cures.

But in stark contrast to those claims, a study published Tuesday in The Journal of the American Medical Association shows 13 young Brazilians with type 1 diabetes have been able to stop taking insulin shots, thanks to a promising treatment with their own stem cells — not embryonic stem cells.

“It’s the first time in the history of type 1 diabetes where people have gone with no treatment whatsoever,” study co-author Dr. Richard Burt of Northwestern Memorial Hospital told The Associated Press.